반응식
C([O:4][CH2:5][C:6]([NH:25][C:26]([O:28][C:29]([CH3:32])([CH3:31])[CH3:30])=[O:27])([CH2:12][CH2:13][CH2:14][CH2:15][B:16]1[O:20][C:19]([CH3:22])([CH3:21])[C:18]([CH3:24])([CH3:23])[O:17]1)[C:7]([O:9][CH2:10][CH3:11])=[O:8])(=O)C.C(=O)([O-])[O-].[K+].[K+]>C(O)C>[C:29]([O:28][C:26]([NH:25][C:6]([CH2:5][OH:4])([CH2:12][CH2:13][CH2:14][CH2:15][B:16]1[O:17][C:18]([CH3:24])([CH3:23])[C:19]([CH3:22])([CH3:21])[O:20]1)[C:7]([O:9][CH2:10][CH3:11])=[O:8])=[O:27])([CH3:32])([CH3:30])[CH3:31]참가 물질
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
A solution of ethyl 2-(acetoxymethyl)-2-(tert-butoxycarbonylamino)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexanoate (12.0 g, 26.3 mmol) in ethanol (100 mL) was treated with solid potassium carbonate (3.62 g, 26.3 mmol) and stirred for 2 h. The solution was filtered and the filtrate was evaporated to dryness. The resulting residue was dissolved in ethyl acetate (150 mL) and washed successively with water (50 mL) and saturated aqueous sodium chloride (50 mL). Organic layer was concentrated and purified using a combiflash system (120 g column, eluting with 20-30% ethyl acetate in heptanes) to give ethyl 2-(tert-butoxycarbonylamino)-2-(hydroxymethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hexanoate (7.0 g, 78%). 1H NMR (CDCl3) δ 5.25 (bs, 1H), 4.00 (m, 2H), 3.91 (d, J=11.3 Hz, 1H), 3.60 (d, J=11.3 Hz, 1H), 1.53-1.46 (m, 1H), 1.23 (s, 9H), 1.21-1.15 (m, 1H), 1.06 (m, 7H), 1.03 (s, 12H), 0.90 (m, 1H), 0.54 (t, J=7.8 Hz, 2H). MS found for C20H38BNO7 m/z[438(M+Na)]
후처리
- filtrationThe solution was filtered
- customthe filtrate was evaporated to dryness
- dissolutionThe resulting residue was dissolved in ethyl acetate (150 mL)
- washwashed successively with water (50 mL) and saturated aqueous sodium chloride (50 mL)
- concentrationOrganic layer was concentrated
- custompurified
- washa combiflash system (120 g column, eluting with 20-30% ethyl acetate in heptanes)
출처 및 근거
- ORD 기록
- ord-45e3041e8c664d99b721b686446a0fe3
- 출처 데이터셋
- uspto-grants-2015_05
- 특허 번호
- US09040703B2
연결된 노트
불러오는 중…